Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Daniel Moon

Peter MacCallum Cancer Institute

Australia

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Professors in Australia Professors in Medical Imaging Medical Imaging professors in Australia

Articles (27)

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (12)

Bradley Erickson

Professor

The University of Iowa

UNITED STATES

View details

Wouter Everaerts

Associate professor

KU Leuven

BELGIUM

View details

Daniel Moon

AUSTRALIA

View details

Thomas Zilli

University of Geneva

SWITZERLAND

View details

Shankar Siva

University of Melbourne

AUSTRALIA

View details

Veeru Kasivisvanathan

University College London

UNITED KINGDOM

View details

Nathan Lawrentschuk

Director

AUSTRALIA

View details

Declan Murphy

sir peter maccallum department of oncology university of melbourne melbourne victoria australia

AUSTRALIA

View details

Haryana Dhillon

Associate Professor in Psychology

University of Sydney

AUSTRALIA

View details

Constanza Vargas

University of Sydney

AUSTRALIA

View details

Anand Swaminath

juravinski cancer centre mcmaster university hamilton ontario canada

CANADA

View details

Phillip Stricker

Conjoint Professor

University of New South Wales

AUSTRALIA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Daniel Moon

Research Interests

Make your next move.

Explore related searches

Articles (27)

Health-related Quality of Life Outcomes of Salvage Metastasis-directed Treatment Versus Elective Nodal Treatment for Oligorecurrent Nodal Prostate Cancer: A Secondary Analysis of the Phase 2, Open-label PEACE V-STORM Randomized Trial.

Effect of [68Ga]Ga-PSMA-11 PET-CT in the diagnosis of prostate cancer in men with equivocal or clinically high-risk non-suspicious findings on multiparametric MRI (PRIMARY2): a multicentre, non-inferiority, phase 3, randomised controlled trial

Long-term outcomes of stereotactic ablative body radiotherapy for primary kidney cancer (TROG 15.03 FASTRACK II): a multicentre, non-randomised, phase 2 study

Ultra-hypofractionated stereotactic ablative body radiotherapy for primary renal cell carcinoma: 5-year outcomes from a pooled analysis of the FASTRACK trials

Quality and Usability of Prostate Cancer Information Generated by Artificial Intelligence Chatbots: A Comparative Analysis

Nuclear Imaging in Renal Cell Carcinoma: Current Evidence and Clinical Applications.

Robotic-assisted radical prostatectomy in patients 80+ years: a multi-centre experience.

Impact of the R.E.N.A.L. complexity score on outcomes of stereotactic ablative body radiotherapy for primary renal cell carcinoma

Stereotactic Ablative Body Radiotherapy (SABR) versus Radiofrequency Ablation and cryoablation for Primary Renal Cell Carcinoma: an economic evaluation of the FASTRACK II trial

Salvage metastasis-directed therapy versus elective nodal radiotherapy for oligorecurrent nodal prostate cancer metastases (PEACE V-STORM): a phase 2, open-label, randomised controlled trial

The Artificial Urinary Sphincter Clinical Outcomes Trial: Primary Results.

The Role of Prostate-specific Membrane Antigen Positron Emission Tomography for Assessment of Local Recurrence and Distant Metastases in Patients with Biochemical Recurrence of Prostate Cancer After Definitive Treatment: A Systematic Review and Meta-analysis.

Early Results from the CONFIRM Trial: Utility of Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography in Active Surveillance for Prostate Cancer.

Pelvic Lymph Node Dissection in Prostate Cancer: Is It Really Necessary? A Multicentric Longitudinal Study Assessing Oncological Outcomes in Patients With Prostate Cancer Undergoing Pelvic Lymph Node Dissection vs Radical Prostatectomy Only.

PSMA-Guided Metastasis-Directed Therapy for Oligometastatic Renal Cell Carcinoma: The Proof-of-Concept PEDESTAL Study.

A Comprehensive Systematic Review and Meta-analysis of the Role of Prostate-specific Membrane Antigen Positron Emission Tomography for Prostate Cancer Diagnosis and Primary Staging before Definitive Treatment.

How PSMA PET is refining risk calculators in the primary prostate diagnostic pathway

NeoAdjuvant pembrolizumab and STEreotactic radiotherapy prior to nephrectomy for renal cell carcinoma (NAPSTER): A phase II randomised clinical trial

Re: Upfront Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors or Targeted Therapy: An Observational Study from the International Metastatic Renal Cell Carcinoma Database Consortium.

A Systematic Review of the Variability in Performing and Reporting Intraprostatic Prostate-specific Membrane Antigen Positron Emission Tomography in Primary Staging Studies.

High prostate‐specific membrane antigen ( <scp>PSMA) positron emission tomography (PET)</scp> maximum standardized uptake value in men <scp>with PI‐RADS</scp> score 4 or 5 confers a high probability of significant prostate cancer

Synchronous vs independent reading of prostate-specific membrane antigen positron emission tomography (PSMA-PET) and magnetic resonance imaging (MRI) to improve diagnosis of prostate cancer.

Prostate‐specific membrane antigen positron emission tomography/computed tomography funding grants free access to superior staging for Australian men with prostate cancer

The Detection of Prostate Cancer with Magnetic Resonance Imaging-Targeted Prostate Biopsies is Superior with the Transperineal vs the Transrectal Approach. A European Association of Urology-Young Academic Urologists Prostate Cancer Working Group Multi-Institutional Study.

Comparison of perioperative outcomes following transperitoneal versus retroperitoneal robot-assisted partial nephrectomy: a propensity-matched analysis of VCQI database.

The PRIMARY Score: Using intra-prostatic PSMA PET/CT patterns to optimise prostate cancer diagnosis.

Robotic partial nephrectomy for hilar renal masses

Collaborators (12)

Bradley Erickson

Wouter Everaerts

Daniel Moon

Thomas Zilli

Shankar Siva

Veeru Kasivisvanathan

Nathan Lawrentschuk

Declan Murphy

Haryana Dhillon

Constanza Vargas

Anand Swaminath

Phillip Stricker

Make your next move.